Drug intelligence / Profile preview

Lat@Lig-QCOS

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Ophthalmic
01

Overview

Lat@Lig-QCOS is an experimental mucoadhesive and corneal-permeable nanoparticle formulation of latanoprost developed for the treatment of glaucoma. The system utilizes lignin-based nanoparticles encapsulated with latanoprost and coated with quaternary ammonium chitosan oligosaccharide (QCOS). This positively charged nanocarrier enhances intraocular drug bioavailability by promoting ocular mucoadhesion and modulating corneal epithelial tight junctions to facilitate paracellular transport. In preclinical studies, Lat@Lig-QCOS demonstrated a 2.2-fold increase in corneal permeability and a significantly greater reduction in intraocular pressure (IOP) compared to free latanoprost and commercial formulations like Xalatan, with effects sustained for up to 10 hours.

Other names
Lat@Lig-QCOS nanoparticleslatanoprost-loaded lignin-quaternary ammonium chitosan oligosaccharide nanoparticles
02

Targets

PTGFR (Prostaglandin F2 alpha receptor)

Beyond the preview

Go deeper on Lat@Lig-QCOS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lat@Lig-QCOS.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call